Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05229341 · ClinicalTrials.gov registry record · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
A NA study of Thyroid Gland Carcinoma, sponsored by City of Hope Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 1,450
- Enrollment target
- 1
- Study location
NCT05229341 is a NA study of Thyroid Gland Carcinoma that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 1,450 participants, above the 314-participant average among 3 other Thyroid Gland Carcinoma trials with a reported enrollment target (362% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05229341, a NA study of Thyroid Gland Carcinoma, is actively recruiting participants, sponsored by City of Hope Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,450 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial evaluates deoxyribonucleic acid (DNA) methylation signatures in diagnosing and managing thyroid nodules. The purpose of this research is to develop a new test for thyroid cancer. This test will use needle biopsies (small collections of tissue with a needle) from the thyroid to determine whether the participant has a malignant (cancer) or benign (not showing cancer) thyroid tumor. The information learned from this trial may help develop a more accurate test so that patients do not have unnecessary surgeries for nodules that are thought to be suspicious but are actually benign.
Conditions Studied
Interventions
- OTHER Electronic Health Record Review
- PROCEDURE Diagnostic Procedure
- PROCEDURE Needle Biopsy
Study Locations (1)
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,450 participants |
| Start Date | 2021-10-22 |
| Est. Completion | 2026-10-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05229341
The ClinicalTrials.gov registry entry for NCT05229341 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,450 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 314-participant average among 3 other Thyroid Gland Carcinoma trials with a reported enrollment target (362% higher). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thyroid Gland Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Electronic Health Record Review is the first listed.
NCT05229341 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05229341 about?
NCT05229341 is a clinical study titled "Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules". This clinical trial evaluates deoxyribonucleic acid (DNA) methylation signatures in diagnosing and managing thyroid nodules. The purpose of this research is to develop a new test for thyroid cancer. This test will use needle biopsies (small collections of tissue with a needle) from the thyroid to de...
What is the current status of trial NCT05229341?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,450 participants. The study started on 2021-10-22. Estimated completion is 2026-10-22.
What conditions does trial NCT05229341 study?
This clinical trial studies the following conditions: Thyroid Gland Carcinoma.
What interventions are being tested in trial NCT05229341?
The interventions under investigation include: Electronic Health Record Review (OTHER), Diagnostic Procedure (PROCEDURE), Needle Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT05229341?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05229341 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Gland Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
RECRUITING
-
Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters
RECRUITING
-
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.